|
|
Multiplex approach to DNA methylation assays in exhaled breath condensate
|
5R03CA132145-02
|
$83,000
|
$83,000
|
HAN, WEIGUO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-04
|
$469,320
|
$469,320
|
Han, James
|
AMBERGEN, INC
|
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
5U01CA098710-06
|
$550,218
|
$550,218
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
|
Roles of Zinc Transporter ZIP4 (SLC39A4) in Pancreatic Cancer Pathogenesis
|
1R21CA133604-01A2
|
$168,850
|
$42,213
|
LI, MIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Role of AIB3 in Mammary Gland and Breast Cancer
|
5R01CA119689-05
|
$280,899
|
$280,899
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Familial and Early Onset Colorectal Cancer
|
2R01CA072851-14
|
$342,796
|
$342,796
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Use of CCI-779 in multiple myeloma
|
5R21CA121464-02
|
$319,950
|
$79,988
|
LICHTENSTEIN, ALAN
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
|
Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE
|
3P50CA105009-05S1
|
$1,193,174
|
$596,587
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Partners Southwestern Clinical Epidemiology/Validation
|
5U01CA086381-10
|
$917,404
|
$917,404
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Prospective Study of DNA Repair Gene Variants in Breast Cancer
|
5R01CA118447-03
|
$329,823
|
$329,823
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Biochemical Markers in the Nurses? Health Study Cohort
|
2U01CA049449-20A1
|
$1,118,195
|
$279,549
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
5R01CA065725-13
|
$408,636
|
$408,636
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
5U01CA098233-07
|
$1,403,224
|
$1,403,224
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Genetic Variants in Mitochondrial Genome and Skin Cancer Risk
|
1R03CA141606-01
|
$88,750
|
$88,750
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
5K07CA120448-03
|
$141,548
|
$141,548
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Mitochondrial DNA Mutations in Pancreatic Cancer
|
1R21CA133080-01A1
|
$248,462
|
$248,462
|
Tranah, Gregory
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-15
|
$720,409
|
$720,409
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
|
Clinical Correlative Studies of Neuroblastoma
|
5R01CA060104-16
|
$421,986
|
$421,986
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Diagnostic and Prognostic Sarcoma Signatures
|
5U01CA114757-05
|
$1,731,711
|
$1,731,711
|
Triche, Timothy
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-18
|
$266,860
|
$266,860
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-02
|
$666,482
|
$666,482
|
MARIS, JOHN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Hereditary Breast Cancer and Novel Hispanic BRCA Mutations
|
1R03CA139588-01
|
$83,000
|
$83,000
|
WEITZEL, JEFFREY
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Genetics Career Development Program
|
5R25CA085771-09
|
$220,445
|
$11,022
|
WEITZEL, JEFFREY
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Molecular Basis for Spitzoid Tumors
|
5R03CA133925-02
|
$80,500
|
$80,500
|
CELEBI, JULIDE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
$5,996
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
$239,989
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-26
|
$402,500
|
$402,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
A pilot study of statin therapy and risk of malignant glioma
|
5K07CA127468-02
|
$135,513
|
$67,757
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Metropolitan New York Registry of Breast Cancer Families
|
5U01CA069398-16
|
$702,577
|
$702,577
|
TERRY, MARY BETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Modeling ovarian carcinoma by defined genetic alterations
|
5R01CA112354-05
|
$266,292
|
$266,292
|
Nikitin, Alexander
|
CORNELL UNIVERSITY ITHACA
|
|
|
EDRN: Clinical Epidemiology & Validation Centers
|
5U01CA086389-10
|
$668,776
|
$501,582
|
LYNCH, HENRY
|
CREIGHTON UNIVERSITY
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$6,227
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$7,169
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$584,445
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Epidemiology of Syndromic GI Stromal Tumors
|
5R01CA125176-03
|
$631,908
|
$631,908
|
GARBER, JUDY
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Dana-Farber/Harvard SPORE in Breast Cancer
|
3P50CA089393-09S3
|
$24,615
|
$12,308
|
IGLEHART, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Dana-Farber/Harvard SPORE in Breast Cancer
|
5P50CA089393-10
|
$2,179,546
|
$1,089,773
|
IGLEHART, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
|
DF/HCC SPORE in Prostate Cancer
|
5P50CA090381-08
|
$2,463,000
|
$985,200
|
KANTOFF, PHILIP
|
DANA-FARBER CANCER INSTITUTE
|
|
|
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas
|
5P01CA092625-09
|
$3,316,818
|
$3,316,818
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
5R01CA132829-02
|
$396,689
|
$99,172
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
2P30CA023108-31
|
$3,290,263
|
$131,611
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
3P30CA023108-31S2
|
$87,459
|
$3,498
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Etiologic Role of HPV in Keratinocyte Carcinomas
|
5R01CA118443-03
|
$306,741
|
$306,741
|
KARAGAS, MARGARET
|
DARTMOUTH COLLEGE
|
|
|
microRNAs as novel Biomarkers for Pancreatic Ductal Adenocarcinoma
|
5R21CA133715-02
|
$143,910
|
$71,955
|
KORC, MURRAY
|
DARTMOUTH COLLEGE
|
|
|
Focused Genomic Dissection of the Prostate Cancer Risk Variant on Chromosome 8q24
|
5R01CA129991-03
|
$196,509
|
$196,509
|
Stefansson, Kari
|
DECODE GENETICS, INC.
|
|
|
Early Detection of Liver Cancer
|
3U01CA084951-10S2
|
$311,079
|
$311,079
|
Block, Timothy
|
DREXEL UNIVERSITY
|
|
|
Brain Tumors - Immunological and Biological Studies
|
5R37CA011898-39
|
$690,468
|
$690,468
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
|
mTOR Therapy in Prostate Cancer: Signatures of Response and Biology of Resistance
|
5R01CA123175-03
|
$308,811
|
$308,811
|
FEBBO, PHILLIP
|
DUKE UNIVERSITY
|
|
|
Validating Molecular Signature Risk Models of NSCLC
|
5R01CA116648-04
|
$455,257
|
$227,629
|
HARPOLE, DAVID
|
DUKE UNIVERSITY
|
|
Total relevant funding to Genetic Testing for this search: $133,833,813
|
